75
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Helicobacter pylori and CagA Status, Serum Gastrin, Interleukin-8 and Gastric Acid Secretion in Gastric Cancer

Pages 891-898 | Published online: 08 Jul 2009

  • Webb PM, Forman D. Helicobacter pylori as a risk factor for cancer. Balliere's Clin Gastroenterol 1996;9:563-82.
  • Crespi M, Citarda F. Helicobacter pylori and gastric cancer: an overrated risk? Scand J Gastroenterol 1996;31:1041 -6.
  • Danesh J. Helicobacter pylori infection and gastric cancer: systemic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13:851 -6.
  • IARC Working Group. Monographs on the evaluation of the carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. IARC Publications, Geneva 1994;177-241.
  • NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. J Am Men Assoc 1994;272:65-9.
  • Kames WEJ, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophie body gastritis. Gastroenterology 1991;101:167-74.
  • Sakaki N, Momma K, Egawa N, Yamada Y, Kan T, Ishiwata J. The influence of Helicobacter pylori infection on the progression of gastric mucosa atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol 1995;7:S59-62.
  • Kikuchi S, Nakajima T, Kobayashi O, Yamazaki T, Kikuichi M, Mori K, et al. Effect of age on the relationship between gastric cancer and Helicobacter pylori. Tokyo Research Group of Prevention for Gastric Cancer. Jpn J Cancer Res 2000;91:774-9.
  • Baldini L, Pretolani S, Bonvicini F, Miglio F, Epifenio G, Gentiloni-Silvieri N, et al. Effect of Helicobacter pylori infection, age and epithelial cell turnover in a general population at high risk for gastric cancer. Panminerva Med 1999;41:187-92.
  • Handa Y, Saitph T, Kawaguchi M, Misaka R, Tsurui M, Ohno H, et al. Production of secretory component and pathogenesis of gastric cancer in Helicobacter pylori-infected stomach. J Gastroenterol 1999;34Suppl 1:137-42.
  • Araya JC, Villaseca MA, Roa I, Roa JC. Helicobacte r pylori and chronic gastritis: relation between infection and inflammatory activity in a high risk population for gastric cancer. Rev Med Chil 2000; 128:259-65.
  • Testino G, Valentin! M, Cornaggia M. Helicobacter pylori and gastric cancer. Am J Gastroenterol 2000;95:2131 -3.
  • Honig A, Witte F, Mirecka J, Binder C, Schauer A. Helicobacter pylori-induced hyperproliferation : relevance for gastric cancer development in connection with mutagenic factors. Anticancer Res 2000;20:1641-8.
  • Graham D. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol 2000;35 Suppl 1:290-7.
  • Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975;2:58-9.
  • Warren JR, Marshall BJ. Unidentified curved bacteria on gastric epithelium in active chronic gastritis. Lancet 1983;l:1273-5.
  • Konturek PC, Pierzchalski P, Konturek SJ, Meixner H, Faller G, Kirchner T, et al. Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax Expression in human. Scand J Gastroenterol 1999;34:375-83.
  • Peek RM, Moss SF, Tham KT, Perez-Perez GI, Wang S, Miller GG, et al. Helicobacter pylori cagA(+) strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997;89:863-8.
  • Hahm KB, Lee KJ, Choi SY, Kim JH, et al. Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. Am J Gastroenterol 1997:92:1853-7.
  • Hwang H, Dwyer J, Russel RM. Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: are there new roles for preventive factors? Natr Rev 1994:52:75-83.
  • Phull PS, Green CJ, Jacyna MR. A radical view of the stomach; the tole of oxygen-derived free radicals and anti-oxidants in gastroduodenal disease. Eur J Gastroenterol Hepatol 1995;7: 265-74.
  • Eapen CE, Madesh M, Balasubramanian K-A, Pulimood A, Pathau M, Ramakrishma BS. Mucosal mitochondria! function and antioxidant defences in patients with gastric carcinoma. Scand J Gastroenterol 1998;33:975-81.
  • Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642-8.
  • Kuipers EJ, Perez-Perez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophie gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
  • Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
  • Konturek PC, Konturek SJ, Bobrzynski A, Kwiecien N, Obtulowicz W, Stachura J, et al. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophie gastritis. J Physiol Pharmacol 1997;48:365-73.
  • Konturek PC, Bielanski W, Bobrzynski A, Hahn EG, Konturek SJ. Gastric mucosal expression and luminal release of growth factors in gastric carcinoma and duodenal ulcer patients before and after eradication of Helicobacte r pylori. J Physiol Pharmacol 1997:48:375-82.
  • Peterson WL. Gastrin and acid in relation to Helicobacte r pylori. Aliment Pharmacol Ther 1996; 10 Suppl 1:97-102.
  • McCoIl KEL, El-Omar EM, Gillen D. The role of H. pylori infection in the pathophysiology of duodenal ulcer. J Physiol Pharmacol 1997;48:287-96.
  • Konturek PC, Konturek SJ, Sulekova Z, Meixner H, Bielanski W, Starzynska T, et al. Expression of hepatocyte, growth factor, transforming growth factor alpha, Bax and BcI2 and gastrin in humans gastric cancer. Aliment Pharmacol Ther 2001;15:989999.
  • Konturek JW, Bielanski W, Konturek SJ, Domschke W. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J Physiol Pharmacol 1996;47:161 -75.
  • Wang TC, Dangler CA, Chen D, Goldenring JR, Koh TJ, Coffey RJ, et al. Hypergastrinemia leads to atrophy and invasive gastric cancer in transgenic mice. Gastroenterology 1999;! 16:A527.
  • Karczewska E, Konturek SJ. Helicobacter pylori: chorobotwórcze, diagnostyka i leczenie. Nowa Medycyna 1997;4:17-20.
  • Konturek SJ, Kwiecien N, Obtulowicz W, et al. Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients; role of vagal innervations. Gut 1979;20:875-81.
  • Press WH. Numerical recipes. The art of scientific computing. Cambridge: Cambridge University Press; 1992.
  • Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978:8:283-98.
  • Hanley JAZ, McNeil BJ. The meaning and use of area under a Receiver Operating Characteristics (ROC) curve. Radiology 1982:143:29-36.
  • Aziz N, Buchan I, Taylor C, Kingsland CR, Lewis-Jones I. Sperm deformity index: a reliable predictor of the outcome of oocyte fertilization in vitro. Fertil Steril 1996:66:1000-8.
  • Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54:594-606.
  • Forman D, Newell DG, Fullerton F, Yamell JW, Stacey AR, WaId N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BrMed J 1991;302:1302-5.
  • Nomura A, Stemmermann GN, Chyou P-H, Kalo I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-American s in Hawaii. N Engl J Med 1991;325:1132-6.
  • Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991 ;325:1127 -31.
  • Forman D. Essential co-factors in gastric carcinogenesis. In: Hunt RH, Tytgat GJ, editors. Helicobacter pylori basic mechanisms to clinical cure 1996. London: KIuwer Academic; 1996. p. 225-61.
  • Henwood M, Clarke PA, Smith AM, Watson SA. Expression of gastrin in developing gastric adenocarcinoma. Br J Surg 2001 ;88: 564-8.
  • Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
  • Queiroz DMM, Mendes EN, Rocha GA, Oliveira AM, Oliveira CA, Magalhaes PP, et al. cagA-positive Helicobacter pylori and risk for developing gastric cancer carcinoma in Brazil. Int J Cancer 1998;78:135-9.
  • Rugge M, Bussatto G, Cassaro M, Shiao YH, Russo V, Leandro G, et al. Patients younger than 40 years with gastric carcinoma. Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999:85:2506-11.
  • Ekstrom AM, Held M, Hanson L-E, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001:121:784-91.
  • Van Solinge WW, Rehfeld JF. Co-transcription of gastrin and cholecystokinin genes with selective translation of gastrin mRNA in a human gastric carcinoma cell line. FEBS Lett 1992; 309:47-50.
  • Watson SA, Durrant LG, Wencyk PM, Watson AL, Morris DL. Intracellular gastrin in human gastrointestinal tumor cells. J Natl Cancer Inst 1991:83:866-72.
  • Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996:98:1918-29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.